Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
Shafran
S D
SD
Deschênes
J
J
Miller
M
M
Phillips
P
P
Toma
E
E
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D016470:Bacteremia / Q000188:drug therapy*; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D011446:Prospective Studies; D017828:Rifabutin / Q000008:administration & dosage / Q000009:adverse effects*; D014605:Uveitis / Q000139:chemically induced*
D017828:Rifabutin; D004977:Ethambutol; D017291:Clarithromycin